FDA Approves Mimrylo (rusfertide) for the Treatment of Polycythemia Vera

Sep 4, 2026 - 03:00
 0  0
OSAKA, Japan and CAMBRIDGE, Massachusetts, August 28, 2026 – Takeda (TSE:4502/NYSE:TAK) announced U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA)* for Mimrylo (rusfertide) for the treatment of erythrocytosis...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0